Non-AIDS-defining cancer mortality: Emerging patterns in the late HAART era

Journal of Acquired Immune Deficiency Syndromes

Volumn 73, Issue 2, 2016, Pages 190-196

  Zucchetto, Antonella ^a   Virdone, Saverio ^a   Taborelli, Martina ^a   Grande, Enrico ^b   Camoni, Laura ^c   Pappagallo, Marilena ^b   Regine, Vincenza ^c   Grippo, Francesco ^b   Polesel, Jerry ^a   Dal Maso, Luigino ^a   Suligoi, Barbara ^c   Frova, Luisa ^b   Serraino, Diego ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Excess mortality; HIV AIDS; Multiple causes of death; Standardized mortality ratio

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE; AGED; ANUS CANCER; ARTICLE; CANCER MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; COLORECTAL CANCER; CONFIDENCE INTERVAL; DEATH CERTIFICATE; FEMALE; HEAD AND NECK CANCER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ABUSE; ITALIAN (CITIZEN); LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; STATISTICAL SIGNIFICANCE; UTERUS CANCER; YOUNG ADULT; COMPLICATION; EPIDEMIOLOGY; ITALY; MORTALITY; NEOPLASM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS; ITALY; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84966692607     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001033     Document Type: Article

References (30)

1. Vandenhende MA, Roussillon C, Henard S, et al. Cancer-Related causes of death among HIV-infected patients in France in 2010: Evolution since 2000. PLoS One. 2015;10:e0129550.
2. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299.
3. Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384:241-248.
4. Helleberg M, Kronborg G, Larsen CS, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995-2008. Infection. 2012;40:627-634.
5. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010; 50:1387-1396.
6. Schwarcz SK, Vu A, Hsu LC, et al. Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011. AIDS Patients Care STDS. 2014;28:517-523.
7. World Health Organization, WHO. International Statistical Classification of Diseases and Related Health Problems. Tenth Revision (ICD-10). Geneva, Switzerland: WHO; 1992. Available at http://www.who.int/classifications/icd/en/.
8. Whiteside YO, Selik R, An Q, et al. Comparison of rates of death having any death-certificate mention of heart, kidney or liver disease among persons diagnosed with HIV infection with those in the general US population, 2009-2011. Open AIDS J. 2015;9:14-22.
9. Simard EP, Pfeiffer RM, Engels EA. Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods. AIDS. 2012;26:1311-1318.
10. Serraino D, De Paoli A, Zucchetto A, et al. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the post-HAART era. Cancer Epidemiol. 2010;34:257-261.
11. Zucchetto A, Suligoi B, De Paoli A, et al. Excess mortality for non-AIDS-defining cancers among people with AIDS. Clin Infect Dis. 2010; 51:1099-1101.
12. Suligoi B, Zucchetto A, Grande E, et al. Risk factors for early mortality after AIDS in the cART era: a population-based cohort study in Italy. BMC Infect Dis. 2015;15:229.
13. Ancelle-Park R. Expanded European AIDS case definition. Lancet. 1993; 341: 441.
14. ISTAT. Multiple causes of death. Available at http://siqual.istat.it/SIQual/visualizza.do?id=5000131. Accessed January 14, 2016.
15. Dal Maso L, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009;100:840-847.
16. Dal Maso L, Suligoi B, Franceschi S, et al. Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation. J Acquir Immune Defic Syndr. 2014;66:428-435.
17. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume II. The Design and Analysis of Cohort Studies. IARC Scientific Publications. Lyon, France: International Agency for Research on Cancer; 1987.
18. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR) Am J Epidemiol. 1990;131: 373-375.
19. Robbins HA, Pfeiffer RM, Shiels MS, et al. Excess cancers among HIVinfected people in the United States. J Natl Cancer Inst. 2015;107. pii: dju503.doi: 10.1093/jnci/dju503.
20. Raffetti E, Albini L, Gotti D, et al. Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study. BMC Public Health. 2015;15:235.
21. Worm SW, Bower M, Reiss P, et al. Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival: a cohort study. BMC Infect Dis. 2013;13:471.
22. Shiels MS, Cole SR, Kirk GD, et al. A Meta-analysis of the incidence of non-AIDS Cancer in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52:611-622.
23. Coghill AE, Shiels MS, Suneja G, et al. Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol. 2015;33:2376-2383.
24. Gotti D, Raffetti E, Albini L, et al. Survival in HIV-infected patients after a cancer diagnosis in the cART era: results of an Italian Multicenter Study. Plos One. 2014;9:e94768.
25. Wada N, Jacobson LP, Cohen M, et al. Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individuals. AIDS. 2014; 28:257-265.
26. Obel N, Omland LH, Kronborg G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a populationbased nationwide cohort study. PLoS One. 2011;6:e22698.
27. May MT, Justice AC, Birnie K, et al. Injection drug use and Hepatitis C as risk factors for mortality in HIV-infected individuals: the Antiretroviral Therapy Cohort Collaboration. J Acquir Immune Defic Syndr. 2015; 69:348-354.
28. IARC Working group on the Evaluation of Carcinogenic risks in Humans. Biological agents.Volume100B. A review of human carcinogenesis. IARC Monogr Eval Carcinog Risks Hum. 2012;100:1-441.
29. Loos AH, Bray F, McCarron P, et al. Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer. 2004;40:2794-2803.
30. Grippo F, Grande E, Pace M. Cause-of-death reporting: how to measure inaccurate completion. GENUS. 2013;69:25-45.